As biotechnology advances, such as by measuring the degree of aging and delaying the onset of disease, the methods of risk calculation in the insurance industry are expected to change.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
As biotechnology advances, such as by measuring the degree of aging and delaying the onset of disease, the methods of risk calculation in the insurance industry are expected to change.